Menu

Most Extensive Synthetic Genome Project to Date

Study shows the viability of bacteria with human-made, recoded DNA.

May 16, 2019
Ashley P. Taylor

ABOVE: © ISTOCK.COM, DR_MICROBE

Researchers have generated E. coli with a fully synthetic genome in which three codons have been replaced with their synonyms, reports a paper published yesterday (May 15) in Nature. The genome-recoded bacteria are a bit bigger and are slower growing than their wild-type counterparts. But, they are alive.

“It was completely unclear whether it was possible to make a genome this large and whether it was possible to change it so much,” Jason Chin, a molecular biologist at the UK’s Medical Research Council Laboratory of Molecular Biology and the scientist who led the project, tells The Guardian

A synthetic genome is one that scientists have created chemically, then inserted into cells. In 2010, Craig Venter and colleagues created the first organism with a fully synthetic genome by piecing together synthesized pieces of the bacterium Mycoplasma mycoides’s 1 million–base-pair-long genome. 

See “1st Cell with Synthetic Genome

A recoded genome is one in which one or more codons—the three-letter DNA or RNA sequence that tell the cell to add a particular amino acid to a nascent protein, or to stop translation altogether—have been replaced with synonyms or assigned to code for alternative molecules, such as amino acids that cells do not naturally use. In 2013, the lab of Harvard’s George Church recoded the E. coli genome by using gene editing to replace a stop codon with a synonym, STAT reports. Then in 2016, Church’s lab replaced seven codons in parts of the E. coli genome, this time by assembling pieces of synthetic DNA.

In the new study, Chin and his colleagues synthesized the 4 million base pairs of the E. coli genome, making more than 18,000 codon changes as they did so. Specifically, the team replaced two of the codons that encode the amino acid serine with a synonym and did the same for a stop codon, freeing up three codons for future alternative uses. 

“They have taken the field of synthetic genomics to a new level, not only successfully building the largest ever synthetic genome to date, but also making the most coding changes to a genome so far,” Imperial College London’s Tom Ellis, a synthetic biology researcher who was not involved in the study, tells The Guardian.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.